| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
23,910,000 |
| Market
Cap: |
2.39(B) |
| Last
Volume: |
165,174 |
Avg
Vol: |
186,425 |
| 52
Week Range: |
$81.08 - $209.15 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 789 |
| Guru Rank Value : 1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile ICU Medical is an infusion therapy company. Co. has four product lines: Infusion Consumables, which include Clave™ needlefree products, SwabCap and SwabTip disinfecting caps, ClearGuard HD antimicrobial barrier caps for hemodialysis catheters and Tego™ hemodialysis connector used to cap and protect hemodialysis central venous catheter hubs; Infusion Systems, which provide infusion pumps, dedicated IV sets, software and other services; IV Solutions, which provide a supply of IV solutions, irrigation and nutritionals; and Critical Care, which helps clinicians get real-time access to patients' hemodynamic and cardiac status with a portfolio of monitoring systems and sensors and catheters.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
25,835 |
| Total Buy Value |
$0 |
$0 |
$0 |
$4,467,256 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
1,731,983 |
1,733,712 |
1,800,756 |
1,804,487 |
| Total Sell Value |
$183,670,269 |
$183,822,465 |
$195,804,141 |
$196,491,165 |
| Total People Sold |
6 |
6 |
8 |
8 |
| Total Sell Transactions |
12 |
13 |
17 |
23 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Jain Vivek |
Chairman and CEO |
• • – |
2023-03-08 |
4 |
D |
$156.17 |
$207,550 |
D/D |
(1,329) |
23,762 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2023-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,525 |
25,091 |
|
- |
|
| Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2023-03-08 |
4 |
D |
$156.17 |
$139,616 |
D/D |
(894) |
11,606 |
|
- |
|
| Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2023-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,020 |
12,500 |
|
- |
|
| Sanzone Virginia Ruth |
VP, General Counsel |
• – – |
2023-03-07 |
4 |
D |
$157.47 |
$88,813 |
D/D |
(564) |
4,310 |
|
- |
|
| Sanzone Virginia Ruth |
VP, General Counsel |
• – – |
2023-03-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,072 |
4,874 |
|
- |
|
| Voigtlander Christian B. |
Chief Operating Officer |
• – – |
2023-03-07 |
4 |
D |
$157.47 |
$177,784 |
D/D |
(1,129) |
19,407 |
|
- |
|
| Voigtlander Christian B. |
Chief Operating Officer |
• – – |
2023-03-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,145 |
20,536 |
|
- |
|
| Bonnell Brian Michael |
Chief Financial Officer |
• – – |
2023-03-07 |
4 |
D |
$157.47 |
$177,784 |
D/D |
(1,129) |
11,369 |
|
- |
|
| Bonnell Brian Michael |
Chief Financial Officer |
• – – |
2023-03-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,145 |
12,498 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2023-03-07 |
4 |
D |
$157.47 |
$266,754 |
D/D |
(1,694) |
22,566 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2023-03-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,218 |
24,260 |
|
- |
|
| Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2023-03-07 |
4 |
D |
$157.47 |
$67,397 |
D/D |
(428) |
10,480 |
|
- |
|
| Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2023-03-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
965 |
10,908 |
|
- |
|
| Sanzone Virginia Ruth |
VP, General Counsel |
• – – |
2023-03-06 |
4 |
D |
$161.25 |
$135,289 |
D/D |
(839) |
3,802 |
|
- |
|
| Sanzone Virginia Ruth |
VP, General Counsel |
• – – |
2023-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,595 |
4,641 |
|
- |
|
| Voigtlander Christian B. |
Chief Operating Officer |
• – – |
2023-03-06 |
4 |
D |
$161.25 |
$873,975 |
D/D |
(5,420) |
18,391 |
|
- |
|
| Voigtlander Christian B. |
Chief Operating Officer |
• – – |
2023-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,296 |
19,207 |
|
- |
|
| Bonnell Brian Michael |
Chief Financial Officer |
• – – |
2023-03-06 |
4 |
D |
$161.25 |
$873,975 |
D/D |
(5,420) |
10,353 |
|
- |
|
| Bonnell Brian Michael |
Chief Financial Officer |
• – – |
2023-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,296 |
14,957 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2023-03-06 |
4 |
D |
$161.25 |
$998,783 |
D/D |
(6,194) |
21,042 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2023-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,767 |
26,303 |
|
- |
|
| Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2023-03-06 |
4 |
D |
$161.25 |
$100,943 |
D/D |
(626) |
9,943 |
|
- |
|
| Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2023-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,417 |
10,569 |
|
- |
|
| Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2023-02-02 |
4 |
AS |
$200.00 |
$346,200 |
D/D |
(1,731) |
9,152 |
|
-2% |
|
1476 Records found
|
|
Page 4 of 60 |
|
|
0.95 (0.96%) 
